Overview Randomized Placebo-Controlled Study of ISA247 in Plaque Psoriasis Status: Completed Trial end date: 2005-10-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine which dose of voclosporin is effective in the treatment of plaque psoriasis compared to placebo. Phase: Phase 3 Details Lead Sponsor: Aurinia Pharmaceuticals Inc.